20
Hikal Limited Bangalore In, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Partnering with Pharmaceutical, Life Sciences, Biotech & Specialty Chemicals Companies to deliver APIs, Intermediate & R&D Services.
One of their significant offerings is Celecoxib, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2017-199 - Rev 03
This Chemical Type CEP, issued on July 05, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2591 associated with this CEP further emphasizes